Benda Pharmaceutical, Inc. Provides 2008 Financial Guidance

Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTC BB:BPMA.OB - News), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today revenue and net income guidance for the full year ended December 31, 2008.

MORE ON THIS TOPIC